Chiron | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Chiron

An SI Board Since May 1996

Posts	SubjectMarks	Bans	Symbol
1352	17	0	CHIR

Emcee: Dahmane Dahmani	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
627	arnie- Dow Jones ran a story stating that Cephalon was using this options stra	Nathan L.	-	4/18/1997
626	Celeryroot...Great Name: CEPH has been strutting down the walk, hasn'	SStam	-	4/18/1997
625	Temujin, Thanks for info. If they go for 5% then they will go for all since the	j.d.robbins	-	4/17/1997
624	Novartis Interest MY memory (possibly faulty) is that Ciba (Novartis) may acqu	Temujin	-	4/17/1997
623	Am new to the thread but wondering about Cephalon's option to buy Chiron	arnie h	-	4/17/1997
622	SStam, When Ciba-Geigy bought 49% of Chiron I think at the end of 1994 there wa	j.d.robbins	-	4/17/1997
621	David Stone of Cowen, Meg Malloy of H & Q, Peter Ginsberg of Vector, Tim Wi	KurtVedder	-	4/17/1997
620	The conservative FDA maybe looking at any little excuse to delay CEPH in light	celeryroot.com	-	4/17/1997
619	Hi Frank DiLorenzo. Why don't we all send E Mail messages to Chi	SStam	-	4/17/1997
618	To Techperson: I think the tehcnical downside risk here is very low. Chiron h	Frank DiLorenzo	-	4/17/1997
617	Provigil FDA review will not be coming until year-end 1997 or early 1998, which	Techperson	-	4/16/1997
616	I own both CHIR and CEPH. I'm not selling either. Hey, this is what I hav	KurtVedder	-	4/16/1997
615	I doubt that Cephalon will supply Myotrophin at no charge if they are rejected	Jonathan Rothschild	-	4/16/1997
614	He says CHIR is dirt cheap, considering 5 more NDAs to file this year, and stil	Techperson	-	4/15/1997
613	Good post. Obviously, we agree on almost all the facts. I do think "mor	Techperson	-	4/15/1997
612	CardioGenesis and Chiron to Collaborate on Myocardial Ischemia Research Program	Nathan L.	-	4/15/1997
611	Ask your boss if he really believes that Chiron at $18-19 per share has any of	Nathan L.	-	4/15/1997
610	Chiron and Advanced ChemTech Announce Settlement in Patent Dispute biz.yahoo.c	Nathan L.	-	4/15/1997
609	Two other points. Are you saying that the reason Dr. Klien and Dr. Murphy no	KurtVedder	-	4/15/1997
608	My, my. Testy, aren't we? Your response only confirmed my belief that your	KurtVedder	-	4/15/1997
607	Thx for the excellent post - by refusing to do the third clinical trial - there	Phillipa	-	4/15/1997
606	Well Kurt...where is your response??? Why is Myotoptrophin going to be approved	celeryroot.com	-	4/15/1997
605	Sub cutaneous nerve growth factor injections most likely will not work; not eno	Richard gan	-	4/14/1997
604	Check your facts. Why did you say my sell recommendation is based on the Phase	Techperson	-	4/14/1997
603	Phillip, I am not bashing MM. The man is good at analyzing stocks BUT he is no	KurtVedder	-	4/14/1997

Go to reply# or date (mm/dd/yy):